Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4 [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, pharmacokinetics and pharmacodynamics of a single-dose GZR4 in diabetes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• GZR4

Snippet

Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Diabetes | Phase 1 | Status: COMPLETED